Publication | Open Access

Etodolac, a Selective Cyclooxygenase-2 Inhibitor, Induces Upregulation of E-Cadherin and Has Antitumor Effect on Human Bladder Cancer Cells In Vitro and In Vivo

Tumor BiologyUrologyOncologyHas Antitumor EffectGenitourinary CancerMedicineInduces UpregulationPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologySelective Cyclooxygenase-2 InhibitorCancer Research